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Abstract. In recent years, the interest in nanostructured systems to drug delivery has increased 
because they offer several advantages over conventional dosage forms. Solid Lipid 
Nanoparticles (SLN) have been highlighted among these systems because they have 
advantages such as high physical stability, protection against drug degradation and ease of 
scale-up and manufacturing, without using organic solvent. The aim of this work was to 
evaluate the potential of SLN, by in vitro cytotoxicity assays, for dermal drug delivery. SLN of 
three different lipids were prepared by hot high pressure homogenization and the cytotoxicity 
was assessed by 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyl tetrazolium bromide (MTT) test in 
mouse 3T3 fibroblasts and human HaCaT keratinocytes. SLN showed no cytotoxic potential 
suggesting a great potential for dermal application. 
1.  Introduction 
In recent years, the interest in nanostructured systems to drug delivery has increased because they 
offer several advantages over conventional dosage forms such as increased therapeutic efficacy and 
reduction of collateral effects and toxicity [1]. Solid Lipid Nanoparticles (SLN) were developed at the 
beginning of the 1990s as an alternative carrier system to emulsions, liposomes and polymeric 
nanoparticles. They offer several advantages compared to other colloidal systems such as high 
physical stability, protection against drug degradation due to the solid state of lipid matrix and ease of 
scale-up and manufacturing, without using organic solvent. SLN are produced by replacing the liquid 
lipid (oil) of an o/w emulsion by a solid lipid (at both room and body temperature) or a blend of solid 
lipids [2].  
Nanoparticles can cause cytotoxicity by adherence of the particle to the cell membrane, degradation 
and subsequent release of cytotoxic degradation products. Another mechanism is the internalization of 
nanoparticles by cells, intracellular degradation and subsequent toxic effects inside the cell [3]. The 
first step towards assessing the safety of a new formulation often involves in vitro cytotoxicity test 
methods. The majority of cytotoxicity assays used throughout published nanoparticles studies measure 
cell death via colorimetric methods that assess membrane integrity or mitochondrial activity. 
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Mitochondrial activity can be tested using tetrazolium salts as mitochondrial dehydrogenase enzymes 
cleave the tetrazolium ring. Only active mitochondria contain these enzymes; therefore, the reaction 
only occurs in living cells. The most widely used test is the MTT viability assay. MTT is pale yellow 
in solution but produces a dark-blue formazan product within live cells [4].  
Schöler et al. found that the cytotoxicity of SLN assessed by MTT test on murine peritoneal 
macrophages was concentration dependent and influenced by the lipid matrix [5]. The cytotoxicity of 
SLN was also found to be dependent on the type and concentration of surfactant used [6-9]. Therefore, 
the choice of the lipid matrix and the surfactant is essential in order to formulate a safe preparation. 
The aim of this work was to assess the cytotoxic potential of SLN, by in vitro cytotoxicity assays, 
using fibroblasts and keratinocytes that are the predominant resident cells in dermis and epidermis, 
respectively, in order to evaluate the potential of SLN for dermal drug delivery. 
2.  Methods 
2.1.  Solid Lipid Nanoparticles (SLN) preparation 
The solid lipids used, cetyl palmitate (CP), myristyl myristate (MM) and cetyl esters (SS), were kindly 
donated by Croda (Brazil). SLN were produced by hot high pressure homogenization. The solid lipid 
heated to around 10ºC above its melting point. Afterwards, the mixture was added to a hot aqueous 
solution of Pluronic F68 under high agitation in an Ultra-turrax T18 to form a pre-emulsion. The 
pre-emulsion was homogenized using a Panda 2k (Niro Soavi, Italy), applying three homogenization 
cycles at 600 bar and cooled to form the SLNs. 
2.2.  Particle Size and Zeta Potential 
The mean diameter (z-average diameter) and size distribution were measured by photon correlation 
spectroscopy (PCS) (Nano ZS Zetasizer, Malvern Instruments Corp, UK) at 25ºC in polystyrene 
cuvettes with path length of 10 mm. The zeta potential was measured in capillary cells with path 
lengths of 10 mm, using the Nano ZS Zetasizer. Measurements were performed in deionized water 
obtained by a MilliQ system. All the measurements were performed in triplicate and data were 
expressed as the means ± standard deviation (SD).  
2.3.  Physical stability of SLN 
The physical stability of the SLN was evaluated by examining changes of mean particle size and zeta 
potential during storage at 4ºC. 
2.4.  Cytotoxicity assays 
2.4.1.  Cell lines and culture. BALB/c 3T3 cell line was purchased from National Institute of Health-
Baltimore, USA (NIH) and, HaCaT cell line was kindly gifted from Dr. Liudmila L. Kodach 
(Academic Medical Center, Amsterdam University). Both cell lines were routinely grown in DMEM 
supplemented with fetal bovine serum, 15% for BALB/c 3T3 and 10% for HaCaT and, antibiotics 
(100 U/mL penicillin, 10 µg/mL streptomycin) in a humidified incubator with 5% carbon dioxide, at 
37oC.  
2.4.2.  Treatment of cells with CP, MM and SS. Cells, BALB/c 3T3 104 cells/well and HaCaT 
7x103 cells/well, were incubated in 96-well plates until reach the semiconfluence and then treated with 
different concentrations of SLN (10–500 µg/mL final concentrations) for 24 h. Cell viability was 
assessed by the MTT reduction assay. 
2.4.3.  MTT reduction assay. The medium containing riboflavin was removed and 100 µL of  
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) solution (0.5 mg/mL of culture 
medium) was added to each well. After incubation for 4 h at 37ºC, the medium was removed and the 
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formazan crystals solubilized in 100 µL of ethanol. The plate was shaken for 5 min on a plate shaker 
and the absorbance was measured at 570 nm in a microplate reader (ELx800, BioTek Instruments, 
Inc., Winooski, VT) [10] 
2.4.4.  Statistical analysis. Cell viability data were expressed as the means ± standard deviation (SD) 
of experiments. A percentage of viability compared with control wells (the means optical density of 
untreated cells was set to 100% viability) was calculated from the concentration-response curves by 
linear regression analysis. Data from each assay were analyzed statistically by ANOVA. Multiple 
comparisons among group mean differences were checked with the Tukey test. Differences were 
considered significant when the p < 0.05. 
3.  Results and discussion 
3.1.  SLN characterization 
SLN were prepared with three different lipids, cetyl palmitate (CP), myristyl myristate (MM) and cetyl 
ester (SS). The mean diameter, polydispersity index (PI) and zeta potential of SLN are listed in 
Table 1. The SLN dispersions were obtained with high homogeneity (low PI) and both mean diameter 
and zeta potential of the SLN dispersion were close. As shown in Figure 1, SLN dispersions did not 
show any significant changes of particle size and zeta potential when maintained at 4ºC in test period 
(six months), indicating a high physical stability. This can be explained by high zeta potential of the 
SLN dispersions and by the steric stabilization provided by surfactant used (Pluronic F68). 
Table 1. z-average diameter, polydispersity index (PI) and zeta potential and of SLN 
SLN  Diameter (nm) PI Zeta Potential (mV) 
CP 189.0 ± 1.8 0.149 ± 0.037 -34.7 ± 4.1 
MM 185.4 ± 6.3 0.188 ± 0.012 -31.9 ± 2.1 
SS 197.5 ± 3.5 0.234 ± 0.023 -30.5 ± 1.5 
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3.2.  Cytotoxicity of SLN 
The results obtained in cytotoxicity assays are presented in Figure 2. The cytotoxic effect was 
influenced by the lipid matrix, as verified by statistical analysis. The lipid that showed smaller 
reduction in cell viability in the tested concentration range was the SS. Although in some 
concentrations of SLN cell viability was reduced, until the highest concentration tested (500 µg/mL) 
the IC50 (half maximal inhibitory concentration) was not reached for the three lipids in both cell 
showing no cytotoxic potential of the tested SLN dispersions. When compared to results obtained by 
Figure 1. Physical stability of SLN during storage at 4 ºC. (A) Mean diameter; (B) Zeta potential. 
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Marcato et al. [11] in MTT test with polymeric nanoparticles, using the same cell lines, the SLN were 
less cytotoxic.  
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4.  Conclusions  
The results obtained in this work suggest that SLN have a great potential for dermal drug delivery 
because they showed no cytotoxic potential in fibroblasts and keratinocytes cells. 
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Figure 2. Cytotoxicity of SLN in (A) 3T3 fibroblasts and (B) HaCaT keratinocytes. 
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